[Modifications of fibrinolysis and coagulation activity in arteriosclerotic patients treated with a polysulfoester of pentosan (SP-54). I].
D001161:Arteriosclerosis / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects*; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006496:Heparinoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011134:Polysaccharides / Q000627:therapeutic use*; D013464:Sulfuric Acids / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D006496:Heparinoids; D011134:Polysaccharides; D013464:Sulfuric Acids
Modificazioni della fibrinolisi e dell'attività coagulativa in aterosclerotici trattati con un polisolfoestere del pentosano (SP-54).